Hematology

Question 1

Hypo-proliferative normocytic anemia

Answer 1

FLATS

Fe
Lead
ACD
Thalassemia 
Sideroblastic anemia

Question 2

Causes of sideroblastic anemia

Answer 2

1-Drugs (Isoniazid, linezolid, chloramphenicol)
2-Toxin (alcohol, zinc, lead)
3-Nutritional (copper, pyridoxine)
4-MDS
5-HEREDITARY 
6-hypothermia

Question 3

Seminoma chemotherapeutic

Answer 3

BEP

bleomycin
Etoposide
Platinum

Question 4

Sarcoma chemotherapeutic

Answer 4

AIM

Adriamycin
Ifosfamide
Mesna

Question 5

Merkel cell carcinoma immunotherapy

Answer 5

PD-L-1blocker (avelumab)

PD-1 inhibitor ( nivolumab, pembrolizumab)

Question 6

Non-seminoma can be differentiated from seminoma by this marker

Answer 6

AFP is elevated in Non-Semi

Question 7

Protocol for CLL

Answer 7

FCR protocol
Fludarabine
Cyclophosphamide
Rituximab

Question 8

Acute intermittent porphyria

Answer 8

Hydromethylbilane synthase

Check urine porphobilinogen

Question 9

Porphyria cutanea tarda

Answer 9

Uroporphyrinogen decarboxylase

Question 10

X linked protoporphyria (x linked sideroblastic anemia)

Answer 10

Aminolevulinic acid synthase

Question 11

Erythropoietic protoporphyria

Answer 11

Ferrochelatase

Question 12

Score for daily performance status

Answer 12

Karnofsky score

Question 13

Second most common prothrombin gene mutation

Answer 13

Prothrombin G20210A

Question 14

Mutation in GP 1b causing thrombocytopenia

Answer 14

Bernard Soulier syndrome

Question 15

Treatment of methotrexate toxicity other than leucovorin

Answer 15

Glucarpidase

Question 16

First PD-1 inhibitor used

Answer 16

Pembrolizumab

Question 17

P-selectin inhibitors that reduces pain crises.

Answer 17

Crizanlizumab

Question 18

Precursor for NAD to reduce sickle cell crisis.

Answer 18

Oral L glutamine

Question 19

Two or more cytopenias

Answer 19

Evans

Question 20

Common photosensitive disorder

Answer 20

PMLE

Polymorphous light eruption

Question 21

Causes of hemophilia A, B , c

Answer 21

8,9, 11

Question 22

Fibrous changes from neoplasm invasion of normal tissue

Answer 22

Desmoplasia

Question 23

Bodies in RBC in patients with asplenia

Answer 23

Howell Jolly bodies

Question 24

Duration of Trustozumab for HER2 breast cancer

Answer 24

1 year

Question 25

Side effect reaction ccc by peeling of skin of hands and feet

Answer 25

Bergdorf reaction (Hand - Foot syndrome)

Question 26

Duration of aromatase inhibitor for breast cancer

Answer 26

10 years

Question 27

Treatment of this cancer associated with second primary cancer

Answer 27

Hodgkin lymphoma

Question 28

Vitamin reduces the risk of non melanomatous skin cancer

Answer 28

Vit B3 (Nicotinamide)

Question 29

Treatment for advanced recurrent BRCA 1 or 2 positive ovarian cancer

Answer 29

Olaparib (PARP inhibitor)